Indiamed Globals

Mirago 25 mg Tablet contains Mirabegron, a beta-3 adrenergic agonist used in the treatment of overactive bladder (OAB). Mirabegron works by relaxing the bladder muscle, which helps to increase the bladder's storage capacity and reduce the symptoms of OAB such as frequent urination, urgency, and incontinence.

Mirago is available in a strength of 25 mg per tablet and is typically packaged in blister packs containing 30 tablets. This packaging ensures the medication's stability and allows for convenient daily dosing.

The active ingredient, Mirabegron, targets beta-3 adrenergic receptors in the bladder. Activation of these receptors leads to relaxation of the detrusor muscle, thereby increasing bladder capacity and reducing the frequency and urgency of urination.

Common indications for Mirago 25 mg Tablet include:

• Overactive Bladder (OAB): Mirago is used to manage symptoms associated with OAB, including urinary urgency, frequency, and urge urinary incontinence.

The usual dosage and duration of treatment with Mirago are determined by the healthcare provider based on the patient's response and tolerability. It is important to adhere to the prescribed dosage and not to make any adjustments without consulting the healthcare provider.

Common side effects of Mirago may include hypertension, headache, nasopharyngitis, and urinary tract infection. More serious side effects can occur, such as severe allergic reactions or changes in blood pressure. Regular follow-ups with the healthcare provider are recommended to monitor for any adverse effects and to adjust the treatment if needed.

Mirago is manufactured by Sun Pharmaceutical Industries Ltd., a respected pharmaceutical company known for its high-quality products. Patients using Mirago should have regular consultations with their healthcare provider to ensure the medication is working effectively and to manage any potential side effects.

Mirago 25 mg Tablet provides an effective treatment option for individuals with overactive bladder. Its targeted action on beta-3 adrenergic receptors helps to manage and alleviate the symptoms of OAB, improving patient comfort and quality of life. With its proven efficacy and reliable manufacturing, Mirago is a valuable choice in the management of bladder disorders.

• Product Description: Terol LA-4 Capsule contains Tolterodine, a medication used to treat the symptoms of an overactive bladder. It works by relaxing the bladder muscles, helping to control the release of urine and reducing the urge and frequency of urination

Roliten OD 4mg Capsule ER is advised to take it in a dose and duration as per prescription. It can be taken with or without food, but take it at the same time regularly. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.

Some common side effects of this medicine include dry mouth, constipation, diarrhea, urinary retention, and headache. Drinking plenty of water might help you cope up with the side effects. It may also make you feel dizzy or sleepy or make your vision blurry, so it advised not to drive or do anything requiring concentration until you know how it affects you. Consumption of alcohol must be avoided as it can aggravate the side effects. If any of the side effects bother you or persist, consult the doctor without delay.

Before receiving the treatment, inform your doctor if you are on any medication for any other health conditions. You should also inform your doctor if you are pregnant or breastfeeding. Patients with liver or kidney disease must be cautious while receiving the prescription and they must receive regular follow-ups as per the doctor’s advice.

• Treatment of Overactive bladder (OAB) symptoms

• Dryness in mouth
• Constipation
• Headache
• Dizziness
• Sleepiness
• Blurred vision
• Diarrhea

Product Description:
Natrise 30 Tablet contains Tolvaptan, a selective vasopressin V2-receptor antagonist that helps to correct sodium imbalance in the body by promoting water excretion without electrolyte loss. It is often prescribed for patients with low blood sodium levels, helping to maintain proper fluid balance.

Alternative brand names for Tolvaptan include Samsca and Tolvaptan itself

Product Description:
Tolvat 15 Tablet contains Tolvaptan, a vasopressin receptor antagonist that helps regulate water balance in the body by increasing urine output without affecting electrolyte balance. It is commonly prescribed for conditions where fluid retention needs to be controlled, such as heart failure or chronic kidney disease.

Popular alternative brands for Tolvaptan include Samsca and Jinarc

Product Description:
Uriron 100mg SR Tablet contains Nitrofurantoin, an antibiotic that belongs to the class of nitrofuran antimicrobials. It is primarily used in the treatment and prevention of urinary tract infections (UTIs) caused by bacteria, such as E. coli. Nitrofurantoin works by inhibiting bacterial enzymes and proteins essential for their growth and replication, ultimately leading to the destruction of the bacteria.

The sustained release (SR) formulation allows for a slower release of the active ingredient, which provides extended antibacterial action and helps maintain therapeutic drug levels in the body over a longer period.

Uriron is most commonly prescribed for acute uncomplicated UTIs, and it is also used for long-term prophylaxis in individuals prone to recurrent UTIs. Patients are typically advised to take Uriron with food to enhance its absorption and reduce the risk of stomach upset. The course of treatment should be completed as prescribed by the healthcare provider to prevent bacterial resistance.

Patients taking Uriron should ensure adequate hydration and monitor for any symptoms of allergic reactions, such as rash or breathing difficulties. This medication is generally well-tolerated but may cause minor side effects like nausea or discoloration of urine

Product Description: Oxemia 50mg contains Desidustat, a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, which is used to treat anemia in patients with chronic kidney disease (CKD). Anemia is common in CKD patients due to reduced erythropoietin production by the kidneys, leading to a low red blood cell count. Desidustat works by simulating the body’s response to low oxygen levels, promoting the production of erythropoietin and enhancing red blood cell production.

Oxemia provides an oral alternative to injectable erythropoiesis-stimulating agents (ESAs), making it more convenient for patients. The drug helps increase hemoglobin levels, improve oxygen transport in the body, and reduce the need for blood transfusions.

This medication is generally well-tolerated, but side effects may include nausea, fatigue, and elevated liver enzymes. Patients on Oxemia should have regular blood tests to monitor hemoglobin levels and liver function.

Oxemia should be used under medical supervision, and patients are advised to follow the prescribed dosage and inform their healthcare provider about any pre-existing conditions or ongoing medications, as this may impact treatment efficacy and safety.